Qualigen Therapeutics, Inc. (QLGN) has 8 open-market insider trades by 4 insiders since 2020. The most active filer is Kurt H. Kruger, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kurt H. Kruger | Dir | — | 3 | $42K | 2021-08-19 |
| Michael S. Poirier | Chairman | — | 2 | $37K | 2022-06-22 |
| Amy S. Broidrick | Pres | — | 2 | $28K | 2022-06-14 |
| Christopher L. Lotz | PresCFO | — | 1 | $5K | 2021-04-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael S. Poirier | Chairman | Buy | $17K | 2022-06-22 |
| Amy S. Broidrick | President | Buy | $19K | 2022-06-14 |
| Kurt H. Kruger | Director | Buy | $10K | 2021-08-19 |
| Amy S. Broidrick | EVP & Chief Strategy Officer | Buy | $9K | 2021-04-26 |
| Michael S. Poirier | Chairman & President | Buy | $20K | 2021-04-20 |
| Christopher L. Lotz | President & CFO | Buy | $5K |
Companies that share insiders with QLGN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-04-16 |
| Kurt H. Kruger | Director | Buy | $12K | 2020-12-29 |
| Kurt H. Kruger | Director | Buy | $21K | 2020-11-20 |